Stockreport

Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On-Demand Vardenafil for Pulmonary Hypertension [Yahoo! Finance]

Gossamer Bio, Inc.  (GOSS) 
Last gossamer bio, inc. earnings: 3/24 07:00 am Check Earnings Report
PDF Capital-efficient structure with no upfront cash, no cash upon exercise, and limited dilution - Opportunity to expand pulmonary hypertension franchise through complem [Read more]